Polycyclic aromatic hydrocarbons and phenolic antioxidants do not significantly induce carbonyl reductase in human cell lines
Related Experiment Videos
Advances in Experimental Medicine and Biology
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).
Annals of oncology : official journal of the European Society for Medical Oncology·2025
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Protein-Centric Biochemistry Laboratory Experiments from Protein Quantification to Proteomics.
Advances in experimental medicine and biology·2026
Recent Applications of Mass Spectrometry at Clarkson University: An Update.
Advances in experimental medicine and biology·2026
Bottlenecks in Proteomics: An Addendum.
Advances in experimental medicine and biology·2026
Detection of Biomedically Relevant Stilbenes from Wines by Mass Spectrometry: An Update.
Advances in experimental medicine and biology·2026
Application of Ion Mobility Mass Spectrometry in Lipidomics.
Advances in experimental medicine and biology·2026
Glycomics Meets Oncology: The Role of Mass Spectrometry in Cancer Research.
Advances in experimental medicine and biology·2026